candesartan cilexetil has been researched along with Carditis in 5 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
| Excerpt | Relevance | Reference |
|---|---|---|
| " We investigated the effect of a new angiotensin II type 1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-([2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl)-1H-benz imi dazole-7- carboxylate (TCV-116), in an animal model of viral myocarditis induced by encephalomyocarditis virus." | 7.69 | An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis. ( Matsumori, A; Sasayama, S; Tanaka, A; Wang, W, 1994) |
| "We examined effects of an angiotensin-II receptor blockers, candesartan cilexetil, in rats with dilated cardiomyopathy after autoimmune myocarditis." | 3.73 | Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy. ( Aizawa, Y; Inoue, M; Kashimura, T; Kodama, M; Ma, M; Saito, Y; Shirai, K; Suresh, PS; Tachikawa, H; Wahed, MI; Watanabe, K, 2005) |
| "This study examined the role of angiotensin II (Ang-II) in a murine model of viral myocarditis." | 3.72 | Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice. ( Matsumori, A; Miyamoto, T; Sasayama, S; Shioi, T; Uchiyama, K; Yamamoto, K, 2003) |
| " We investigated the effect of a new angiotensin II type 1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-([2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl)-1H-benz imi dazole-7- carboxylate (TCV-116), in an animal model of viral myocarditis induced by encephalomyocarditis virus." | 3.69 | An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis. ( Matsumori, A; Sasayama, S; Tanaka, A; Wang, W, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arumugam, S | 1 |
| Thandavarayan, RA | 1 |
| Palaniyandi, SS | 1 |
| Giridharan, VV | 1 |
| Arozal, W | 1 |
| Sari, FR | 1 |
| Soetikno, V | 1 |
| Harima, M | 1 |
| Suzuki, K | 1 |
| Kodama, M | 2 |
| Watanabe, K | 2 |
| Yamamoto, K | 1 |
| Shioi, T | 1 |
| Uchiyama, K | 1 |
| Miyamoto, T | 1 |
| Sasayama, S | 3 |
| Matsumori, A | 3 |
| Shirai, K | 1 |
| Ma, M | 1 |
| Wahed, MI | 1 |
| Inoue, M | 1 |
| Saito, Y | 1 |
| Suresh, PS | 1 |
| Kashimura, T | 1 |
| Tachikawa, H | 1 |
| Aizawa, Y | 1 |
| Tanaka, A | 1 |
| Wang, W | 1 |
1 review available for candesartan cilexetil and Carditis
| Article | Year |
|---|---|
Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy--lessons from animal experiments.
Topics: Adjuvants, Immunologic; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; B | 1995 |
4 other studies available for candesartan cilexetil and Carditis
| Article | Year |
|---|---|
Candesartan cilexetil protects from cardiac myosin induced cardiotoxicity via reduction of endoplasmic reticulum stress and apoptosis in rats: involvement of ACE2-Ang (1-7)-mas axis.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzym | 2012 |
Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds | 2003 |
Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoimmune Diseases; Benzimidazoles; Biph | 2005 |
An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Body | 1994 |